Search results for "Diagnostic testing"
Insomnia meds get boxed warning; pacemakers prematurely losing power
Details on the latest alerts, recalls, and approvals.
https://acphospitalist.acponline.org/archives/2019/07/fda-update-insomnia-meds-get-boxed-warning.htm
15 Jul 2019
Medicare reports on the 2016 Physician Fee Schedule Value Modifier
For physicians who haven't begun working on the Value Modifier, 2016 is the year for immediate action.
https://acphospitalist.acponline.org/archives/2016/05/coding-physician-fee-schedule-value-modifier.htm
15 May 2016
Experts share stewardship successes, priorities
An executive vice president from The Joint Commission offers an update.
https://acphospitalist.acponline.org/archives/2019/12/qa-experts-share-stewardship-successes-priorities.htm
15 Dec 2019
ACC pathway offers guidance on managing patients presenting to the ED with chest pain
The American College of Cardiology (ACC) assessed the available clinical decision pathways for chest pain and advised on the use of high-sensitivity cardiac troponin to avoid unnecessary testing in patients at low risk for acute coronary syndrome.
https://acphospitalist.acponline.org/archives/2022/10/19/free/acc-pathway-offers-guidance-on-managing-patients-presenting-to-the-ed-with-chest-pain.htm
19 Oct 2022
acp-hosp0912sup:acp-hosp0805sup
The results of several studies testing this hypothesis aredescribed in the following sections, with an emphasis on recentrandomized, controlled trials.
https://acphospitalist.acponline.org/archives/2009/12/acph-200912-hyperglycemia.pdf
23 Nov 2009
acp-hosp0000
Diagnostic testing is dependent on B12 levels; levelsbelow 200 pg/mL require no confirmatory testing; inter-mediate levels (200-300 pg/mL) require MMA andhomocysteine measurements. ... Diagnosis involves a B12 level; when the result is less than200 pg/mL (95%-100% specific), no further testing is required.Intermediate B12 levels (200-300 pg/mL) should be followed
https://acphospitalist.acponline.org/archives/2014/03/acph-201403-bc_t2.pdf
28 Feb 2014